224 related articles for article (PubMed ID: 10674016)
1. Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG).
Shankar AG; Pinkerton CR; Atra A; Ashley S; Lewis I; Spooner D; Cannon S; Grimer R; Cotterill SJ; Craft AW
Eur J Cancer; 1999 Nov; 35(12):1698-704. PubMed ID: 10674016
[TBL] [Abstract][Full Text] [Related]
2. Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study.
Craft A; Cotterill S; Malcolm A; Spooner D; Grimer R; Souhami R; Imeson J; Lewis I
J Clin Oncol; 1998 Nov; 16(11):3628-33. PubMed ID: 9817284
[TBL] [Abstract][Full Text] [Related]
3. Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party.
Craft AW; Cotterill SJ; Bullimore JA; Pearson D
Eur J Cancer; 1997 Jun; 33(7):1061-9. PubMed ID: 9376188
[TBL] [Abstract][Full Text] [Related]
4. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
[TBL] [Abstract][Full Text] [Related]
5. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
Dunst J; Ahrens S; Paulussen M; Rübe C; Winkelmann W; Zoubek A; Harms D; Jürgens H
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):379-84. PubMed ID: 9788419
[TBL] [Abstract][Full Text] [Related]
6. Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones.
Evans R; Nesbit M; Askin F; Burgert O; Cangir A; Foulkes M; Gehan E; Gilula L; Kissane J; Makley J
Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):129-36. PubMed ID: 3881374
[TBL] [Abstract][Full Text] [Related]
7. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
Tural D; Molinas Mandel N; Dervisoglu S; Oner Dincbas F; Koca S; Colpan Oksuz D; Kantarci F; Turna H; Selcukbiricik F; Hiz M
Jpn J Clin Oncol; 2012 May; 42(5):420-6. PubMed ID: 22416252
[TBL] [Abstract][Full Text] [Related]
8. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial.
Dunst J; Jürgens H; Sauer R; Pape H; Paulussen M; Winkelmann W; Rübe C
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):919-30. PubMed ID: 7607966
[TBL] [Abstract][Full Text] [Related]
9. Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.
Yock TI; Krailo M; Fryer CJ; Donaldson SS; Miser JS; Chen Z; Bernstein M; Laurie F; Gebhardt MC; Grier HE; Tarbell NJ;
J Clin Oncol; 2006 Aug; 24(24):3838-43. PubMed ID: 16921035
[TBL] [Abstract][Full Text] [Related]
10. Intensive combined modality therapy including low-dose TBI in high-risk Ewing's Sarcoma Patients.
Kinsella TJ; Glaubiger D; Diesseroth A; Makuch R; Waller B; Pizzo P; Glatstein E
Int J Radiat Oncol Biol Phys; 1983 Dec; 9(12):1955-60. PubMed ID: 9463099
[TBL] [Abstract][Full Text] [Related]
11. No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.
Bacci G; Picci P; Ruggieri P; Ferrari S; Mercuri M; Fabbri N; Rosito P; Barbieri E; Ferraro A; Casadei R
J Chemother; 1993 Aug; 5(4):247-57. PubMed ID: 8229153
[TBL] [Abstract][Full Text] [Related]
12. Ewing's sarcoma: experience with 12 cases.
Zülfikar B; Gedikoğlu G
J Chemother; 1992 Feb; 4(1):50-5. PubMed ID: 1403071
[TBL] [Abstract][Full Text] [Related]
13. Ewing's sarcoma treatment in Scandinavia 1984-1990--ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV.
Nilbert M; Saeter G; Elomaa I; Monge OR; Wiebe T; Alvegård TA
Acta Oncol; 1998; 37(4):375-8. PubMed ID: 9743460
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.
Bacci G; Picci P; Ferrari S; Mercuri M; Brach del Prever A; Rosito P; Barbieri E; Tienghi A; Forni C
Cancer; 1998 Mar; 82(6):1174-83. PubMed ID: 9506366
[TBL] [Abstract][Full Text] [Related]
15. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.
Nesbit ME; Gehan EA; Burgert EO; Vietti TJ; Cangir A; Tefft M; Evans R; Thomas P; Askin FB; Kissane JM
J Clin Oncol; 1990 Oct; 8(10):1664-74. PubMed ID: 2213103
[TBL] [Abstract][Full Text] [Related]
16. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.
Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in the treatment of Ewing's sarcoma. The Ewing's Sarcoma Study Group of the German Society of Paediatric Oncology CESS 81.
Sauer R; Jürgens H; Burgers JM; Dunst J; Hawlicek R; Michaelis J
Radiother Oncol; 1987 Oct; 10(2):101-10. PubMed ID: 3423301
[TBL] [Abstract][Full Text] [Related]
18. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.
Ferrari S; Mercuri M; Rosito P; Mancini A; Barbieri E; Longhi A; Rimondini S; Cesari M; Ruggieri P; Di Liddo M; Bacci G
J Chemother; 1998 Dec; 10(6):484-91. PubMed ID: 9876058
[TBL] [Abstract][Full Text] [Related]
19. Results of multimodal therapy in Ewing's sarcoma: a retrospective analysis of 20 patients.
Ben-Arush M; Kuten A; Perez-Nahum M; Cohen Y; Bialik V
J Surg Oncol; 1991 Sep; 48(1):51-5. PubMed ID: 1890840
[TBL] [Abstract][Full Text] [Related]
20. Late follow-up of a short-term intensive regimen for Ewing's sarcoma.
Marcus RB; Springfield DS; Graham-Pole JR; Heare TC; Enneking WF; Million RR
Am J Clin Oncol; 1991 Oct; 14(5):446-50. PubMed ID: 1951181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]